The key questions that were discussed throughout this program were:
- Under the AIA’s inter partes review, who bears the burden of proof for demonstrating unpatentability?
- Under which sections of the Patent Act can challenges be brought to inter partes review?
- What are the timelines for filing petitions for inter partes review? What are the fees?
- What are the criteria for granting petitions for inter partes review?
- To what extent do Federal Rules of Evidence apply to inter partes review?
- How does the filing of Declaratory Judgment affect rights to pursue inter partes review?
- When is estoppel triggered in the context of inter partes review?
- How do discovery and Markman hearings in the context of inter partes review compare to traditional litigation?
- How do stays work with regard to inter partes review?
- How can failed patent challenges in inter partes review lead to a greater likelihood of the determination of willful infringement?
- To what extent do intervening rights exist for new claims incorporated into patents after inter partes review ?
Click here to learn more about this program.
Related Insights
02 June 2025
Events
Biotech Panel Discussion & Happy Hour
Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
03 June 2025
Events
Biotech Breakfast + Office Hours
Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.
30 June 2025
Events
AHLA Annual Meeting
Foley partners Judy Waltz, chair of the firm’s Health Care Practice Group, and Leah D'Aurora Richardson are speaking in the American Health Law Association’s (AHLA) Annual Meeting in San Diego, CA. Waltz is hosting the session “Evolving Expectations: Medicare Advantage Compliance for Plans and Providers,” and Richardson is speaking in the session “Getting Aligned: Structuring Strategic Affiliations for Community Providers.”